|
|||||
|
|
Use of the PD‐1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy |
|
| Authors: | C. L. Boils D. N. Aljadir A. W. Cantafio |
| Abstract: | |
| Keywords: | clinical research/practice immunosuppression/immune modulation kidney transplantation/nephrology organ transplantation in general cancer/malignancy/neoplasia: chemotherapy rejection signaling/signaling pathways kidney (allograft) function/dysfunction |